This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Cornell University. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Bishnu De
Introduction
Bishnu De is a notable inventor based in New Hyde Park, NY (US). He has made significant contributions to the field of gene therapy, particularly in addressing alpha 1-antitrypsin (AAT) deficiency. His innovative work has the potential to impact many lives.
Latest Patents
Bishnu De holds a patent for an oxidation-resistant AAT gene therapy. This gene therapy treatment involves a plasmid or viral vector, such as an AAV, that codes for an elastase- or cathepsin G-inhibiting, oxidation-resistant human AAT. The therapy includes a substitution at specific sites, such as Met358 and/or Met351, which enhances its effectiveness.
Career Highlights
Bishnu De is affiliated with Cornell University, where he conducts his research and development. His work at this prestigious institution has allowed him to explore innovative solutions in the field of gene therapy.
Collaborations
He has collaborated with notable colleagues, including Ronald G Crystal and Katie Stiles, who share his commitment to advancing medical science through innovative research.
Conclusion
Bishnu De's contributions to gene therapy exemplify the spirit of innovation in addressing critical health issues. His work continues to pave the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile